Netris Pharma
Oncology biopharma developing anti-Netrin-1 antibodies to overcome cancer treatment resistance, spun out of Centre Léon Bérard in Lyon
Highlights
- New on EvolcAdded 2026-11-02
About Netris Pharma
NETRIS Pharma develops first-in-class therapeutics that target Netrin-1 to overcome resistance to chemotherapy, targeted therapy and immunotherapy in cancer. Its lead product, NP137, is an anti-Netrin-1 monoclonal antibody that the company describes as in clinical development across several solid tumour types.
The company's stated customers are cancer patients, and its work is directed at clinical development partners and research collaborators.
NETRIS Pharma was founded in 2008 and is headquartered in Lyon, France. It is the first spin-off of Centre Léon Bérard and the Cancer Research Center of Lyon (CRCL), and is hosted at Centre Léon Bérard. The company reports a Horizon Europe funding award of €7.25 million for a Phase 2b trial in head and neck cancer.
Product: NP137, an anti-Netrin-1 monoclonal antibody in clinical development for solid tumours.
Jobs at Netris Pharma
Leadership
- Patrick Mehlen · Chief Executive OfficerSource: company website
- Christophe Guichard · Chief Financial OfficerSource: company website
More biotech & pharma companies
Neuro-Sys
Preclinical neuroscience research services for pharmaceutical, biotech and academic organizations developing CNS and PNS therapiesNew on EvolcNG Biotech
Rapid in vitro diagnostic tests for healthcare professionals, patients and global partnersNew on EvolcNoraker
Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regenerationNew on EvolcNovalix
Preclinical drug discovery services for biotechnology and pharmaceutical companiesNew on EvolcNovaptech
Custom aptamer development, assays and biosensors for biotechnology, pharmaceutical, academic and agri-food organizationsNew on EvolcOddifact
AI platform that prepares orphan drug programs for rare diseases and hands them to pharma partners for developmentYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Universal AnalyticsMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
